Yongfen Xu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Protein Protein

Top Venues

The EMBO journal

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal 42 (6) (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal 42 (6) (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal 42 (6) (2023)
Yuqiang Zhang, Yunpeng Dai, Jiaxin Wang, Yan Xu, Zhe Li, Jinfeng Lu, Yongfen Xu, Jin Zhong, Shou-Wei Ding, Yang Li
Mouse circulating extracellular vesicles contain virus-derived siRNAs active in antiviral immunity. The EMBO journal 41 (11) (2022)
Mingzhe Guo, Liqing Ye, Tao Yu, Lin Han, Qingchao Li, Peilan Lou, Tianyu Gan, Xia Jin, Hui Xiao, Guangxun Meng, Jin Zhong, Yongfen Xu
IL-1β Enhances the Antiviral Effect of IFN-α on HCV Replication by Negatively Modulating ERK2 Activation. ACS infectious diseases 6 (7) (2020)